Protein detail
CSF1R
Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)
Entry name CSF1R | UniProt ID | EVMP confidence score 0.63 |
Supporting publications (n) 6 | Transmembrane count 1 | Protein classification Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteinsTransporters |
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40Basic Information13
Protein Names
Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)
Protein Class (11)
Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteinsTransporters
Protein Function (12)
- Predicted intracellular proteins
- ENZYME proteins:Transferases
- Human disease related genes:Cancers:Cancers of the breast and female genital organs
- Human disease related genes:Nervous system diseases:Neurodegenerative diseases
- CD markers
- RAS pathway related proteins
- Enzymes
- Cancer-related genes:Candidate cancer biomarkers
- Transporters:Accessory Factors Involved in Transport
- Kinases:Tyr protein kinases
Page 1 of 2
Transmembrane
518..538; Helical
Transmembrane Count
1
Ensembl
Entrez Gene Symbol
Gene Synonym (4)
C-FMSCD115CSFRFMS
Gene Description
Colony stimulating factor 1 receptor
Chromosome
5
Position
150053291-150113372
Supporting publications (n)
6
EVMP confidence score
0.63
Fluorescence & Localization2
Single-Nuclei Brain Specificcommitted oligodendrocyte precursor
Function & Pathway8
Protein Function (12)
- Predicted intracellular proteins
- ENZYME proteins:Transferases
- Human disease related genes:Cancers:Cancers of the breast and female genital organs
- Human disease related genes:Nervous system diseases:Neurodegenerative diseases
- CD markers
- RAS pathway related proteins
- Enzymes
- Cancer-related genes:Candidate cancer biomarkers
- Transporters:Accessory Factors Involved in Transport
- Kinases:Tyr protein kinases
Page 1 of 2
Cellular Component (6)
Molecular Function (8)
Biological Process (3)
KEGG (11)
- hsa04010 MAPK signaling pathway
- KEGG:hsa04014 Ras signaling pathway
- KEGG:hsa04015 Rap1 signaling pathway
- KEGG:hsa04060 Cytokine-cytokine receptor interaction
- KEGG:hsa04061 Viral protein interaction with cytokine and cytokine receptor
- KEGG:hsa04151 PI3K-Akt signaling pathway
- KEGG:hsa04380 Osteoclast differentiation
- KEGG:hsa04640 Hematopoietic cell lineage
- KEGG:hsa05200 Pathways in cancer
- KEGG:hsa05202 Transcriptional misregulation in cancer
Page 1 of 2
Reactome (6)
Canonical Pathways (3)
- M64 Pid s1p s1p4 pathway
- M103 Pid s1p s1p1 pathway
- M155 Pid s1p meta pathway
Mediation Categories (3)
Clinical-translation mediationImmune mediationReceptor-signaling mediation
Relations & Evidence75
Enzyme-Mediated Modification (4)
4 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| CSF1R | PTPN2 | P17706 | Y | 809 | phosphorylation | NCI-PID_ProtMapperProtMapper | ProtMapper:16705167 |
| CSF1R | PTPN1 | P18031 | Y | 809 | phosphorylation | NCI-PID_ProtMapperProtMapper | ProtMapper:16477024 |
| CSF1R | IL34 | Q6ZMJ4 | Y | 708 | phosphorylation | REACH_ProtMapperSparser_ProtMapperProtMapper | ProtMapper:29796177 |
| CSF1R | IGF1R | P08069 | Y | 699 | phosphorylation | KEA | KEA:17570479 |
Ligand-Receptor Signaling (66)
66 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| cell_adhesion | cell_adhesion | OmniPath | Yes | Yes | No | Yes | No |
| transmembrane | transmembrane | UniProt_location | No | No | No | Yes | No |
| transmembrane | transmembrane | UniProt_topology | No | No | No | Yes | No |
| transmembrane | transmembrane | UniProt_keyword | No | No | No | Yes | No |
| transmembrane_predicted | transmembrane | OmniPath | No | No | No | Yes | No |
| transmembrane | transmembrane | GO_Intercell | No | No | No | Yes | No |
| transmembrane | transmembrane | CellPhoneDB | No | No | No | Yes | No |
| transmembrane | transmembrane | TopDB | No | No | No | Yes | No |
| transmembrane | transmembrane | LOCATE | No | No | No | Yes | No |
| transmembrane | transmembrane | Ramilowski_location | No | No | No | Yes | No |
Regulatory Interaction Network (4)
4 records.
| Source Protein Symbol | Source UniProt ID | Target Protein Symbol | Target UniProt ID | Is Directed | Is Stimulation | Is Inhibition | Database | References |
|---|---|---|---|---|---|---|---|---|
| IL34 | Q6ZMJ4 | CSF1R | P07333 | Yes | Yes | No | iTALKICELLNETSIGNORProtMapperHINTDIPCellChatDBtalklrscConnectIntActRamilowski2015_Baccin2019Ramilowski2015CellPhoneDBReactome_LRdbBaccin2019CellinkerREACH_ProtMapperSTRING_talklrEMBRACECellTalkDBFantom5_LRdbSparser_ProtMapperconnectomeDB2020LRdb | DIP:22483114IntAct:22483114connectomeDB2020:22729249HINT:22483114ICELLNET:26095744scConnect:18467591LRdb:22729249CellTalkDB:22729249Baccin2019:30205037Cellinker:31616414SIGNOR:24890514HINT:23478061SIGNOR:39416792DIP:23478061Ramilowski2015:22729249IntAct:23478061ProtMapper:29796177talklr:22729249 |
| CSF1R | P07333 | CTND1 | O60716 | Yes | Yes | No | REACH_ProtMapperSIGNORSparser_ProtMapperProtMapper | ProtMapper:21049007SIGNOR:21049007 |
| CSF1 | P09603 | CSF1R | P07333 | Yes | Yes | No | iTALKGuide2Pharma_LRdbICELLNETSIGNORHINTUniProt_LRdbDIPHPMR_talklrHPMRCellChatDBHPRD_LRdbDLRP_CellinkertalklrscConnectHPRDCui2007IntActDLRP_talklrRamilowski2015_Baccin2019Guide2Pharma_CellinkerWangRamilowski2015HPMR_LRdbCellPhoneDBGuide2Pharma_talklrHPRD_talklrBaccin2019CellinkerSTRING_talklrEMBRACECellCallGuide2PharmaCellTalkDBFantom5_LRdbHPMR_CellinkerconnectomeDB2020SPIKE_LCLRdbSPIKE | HINT:22483114HPMR:7883784HPMR:1702217Baccin2019:2408759connectomeDB2020:7883784Baccin2019:7883784IntAct:26235028IntAct:22153499IntAct:22483114ICELLNET:26095744HPRD:8355686HPRD:2408759LRdb:2408759connectomeDB2020:8355686SIGNOR:24890514CellTalkDB:8355686DIP:22483114Cellinker:7883784DIP:22153499Baccin2019:8355686IntAct:22902366HINT:8355686Cellinker:2408759SIGNOR:39416792Cellinker:8355686HINT:22153499HINT:26235028DIP:22902366DIP:26235028connectomeDB2020:2408759LRdb:8355686LRdb:7883784HINT:22902366 |
| CSF1R | P07333 | PLCG2 | P16885 | Yes | Yes | No | SIGNOR | SIGNOR:24890514 |
Sequence, Structure & Domains15
Sequences
Length
972
Mass
107,984
Sequence
MGPGVLLLLLVATAWHGQGIPVIEPSVPELVVKPGATVTLRCVGNGSVEWDGPPSPHWTLYSDGSSSILSTNNATFQNTGTYRCTEPGDPLGGSAAIHLYVKDPARPWNVLAQEVVVFEDQDALLPCLLTDPVLEAGVSLVRVRGRPLMRHTNYSFSPWHGFTIHRAKFIQSQDYQCSALMGGRKVMSISIRLKVQKVIPGPPALTLVPAELVRIRGEAAQIVCSASSVDVNFDVFLQHNNTKLAIPQQSDFHNNRYQKVLTLNLDQVDFQHAGNYSCVASNVQGKHSTSMFFRVVESAYLNLSSEQNLIQEVTVGEGLNLKVMVEAYPGLQGFNWTYLGPFSDHQPEPKLANATTKDTYRHTFTLSLPRLKPSEAGRYSFLARNPGGWRALTFELTLRYPPEVSVIWTFINGSGTLLCAASGYPQPNVTWLQCSGHTDRCDEAQVLQVWDDPYPEVLSQEPFHKVTVQSLLTVETLEHNQTYECRAHNSVGSGSWAFIPISAGAHTHPPDEFLFTPVVVACMSIMALLLLLLLLLLYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLSPGQDPEGGVDYKNIHLEKKYVRRDSGFSSQGVDTYVEMRPVSTSSNDSFSEQDLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERDYTNLPSSSRSGGSGSSSSELEEESSSEHLTCCEQGDIAQPLLQPNNYQFC
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=P07333-1; Sequence=Displayed; Name=2; IsoId=P07333-2; Sequence=VSP_047757, VSP_047758
Alternative Sequence
297..306; ESAYLNLSSE -> GTPSPSLCPA (in isoform 2); 307..972; Missing (in isoform 2)
3D Structural Models
Turn
55..57; 158..160; 270..272; 443..445; 605..608; 684..686; 742..744; 806..808
Helix
76..78; 132..137; 143..145; 169..171; 373..375; 566..568; 573..575; 579..581; 624..640; 671..683; 752..771; 781..783; 788..790; 798..800; 803..805; 819..821; 824..829; 834..849; 863..870; 883..892; 897..899; 903..913
Beta Strand
22..25; 27..32; 38..43; 49..51; 58..62; 64..73; 80..85; 95..101; 108..111; 113..118; 123..125; 127..130; 139..142; 154..157; 161..166; 173..181; 184..187; 191..196; 204..208; 210..215; 216..218; 220..231; 234..239; 248..252; 257..267; 274..282; 285..298; 300..304; 309..314; 319..329; 332..338; 340..342; 351..354; 361..368; 377..385; 388..411; 414..425; 428..437; 446..454; 456..459; 466..473; 479..488; 493..498; 551..553; 556..560; 582..590; 592..604; 609..618; 649..653; 655..658; 660..664; 784..786; 792..794; 809..811; 815..817
3D Structure
X-ray crystallography (26)
Domain & Motif Annotations
Compositional Bias
928..940; Low complexity
Domain (CC)
The juxtamembrane domain functions as autoinhibitory region. Phosphorylation of tyrosine residues in this region leads to a conformation change and activation of the kinase.; DOMAIN: The activation loop plays an important role in the regulation of kinase activity. Phosphorylation of tyrosine residues in this region leads to a conformation change and activation of the kinase.
Domain (FT)
21..104; Ig-like C2-type 1; 107..197; Ig-like C2-type 2; 203..290; Ig-like C2-type 3; 299..399; Ig-like C2-type 4; 402..502; Ig-like C2-type 5; 582..910; Protein kinase
Region
542..574; Regulatory juxtamembrane domain; 796..818; Activation loop; 918..950; Disordered
Protein Families (3)
- Protein kinase superfamily
- Tyr protein kinase family
- CSF-1/PDGF receptor subfamily
Sequence Similarities
Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
Clinical Relevance9
Disease Involvement (5)
Cancer-related genesDisease variantFDA approved drug targetsNeurodegenerationProto-oncogene
Related Diseases (11)
Biomarker
Phase 3; Approved; Phase 1/2; Phase 2; Phase 1
Drug Targets
FDA approved drug targets
Drugs (56)
CENISERTIBPEXIDARTINIB HYDROCHLORIDENULLLINIFANIBVATALANIBAST-487IMATINIBIMC-CS4GO-6976TANDUTINIBAMG-820DACTOLISIBVIMSELTINIBGW-2580PAZOPANIBPANOBINOSTATEDICOTINIBPD-0166285CEDIRANIBCT-1578ARRY-382ALSTERPAULLONEPEXIDARTINIBCABIRALIZUMABBLZ-945QUIZARTINIBMCS-110ANTI-C-FMS MONOCLONAL ANTIBODY AMG 820DOVITINIBSP-600125NVP-TAE684MASITINIBAXATILIMABPROGESTINCHEMBL:CHEMBL546797SORAFENIBCHEMBL:CHEMBL365617PLX-5622DASATINIB ANHYDROUSENMD-2076RG-1530KENPAULLONEILORASERTIBEMACTUZUMABHESPERADINPD-360324SUNITINIBPLX-7486ENTRECTINIBBAY 61-3606CYC-116SERALUTINIBJNJ-7706621GW843682XSULFATINIBPLX7486
Interaction Protein (2)
ENSG00000133216ENSG00000135333
Interaction Count
2
Interaction Dataset
intact_biogrid
Supporting Publications6
| PMID | Title | Abstract |
|---|---|---|
| 31805958 | Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. | No abstract available |
| 33592500 | A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia. | No abstract available |
| 34599510 | Inflammatory capacity of exosomes released in the early stages of acute pancreatitis predicts the severity of the disease. | In particular, an increase in the amount of S100A8 and S100A9 carried by exosomes of severe pancreatitis suggests that the mechanism of action of exosomes is mediated by the effect of these proteins on NADPH oxidase. |
| 37322475 | Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration. | No abstract available |
| 38895962 | A fast and sensitive size-exclusion chromatography method for plasma extracellular vesicle proteomic analysis. | No abstract available |
| 39001700 | Optimized AF4 combined with density cushion ultracentrifugation enables profiling of high-purity human blood extracellular vesicles. | No abstract available |